Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.12 | EZH2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg38_v1_chr7_-_148884159_148884255 | -0.44 | 1.5e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_33235987 | 3.14 |
ENST00000375422.6
ENST00000375413.8 ENST00000354297.9 |
BPIFA1
|
BPI fold containing family A member 1 |
chr19_+_50649445 | 2.54 |
ENST00000425202.6
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr5_-_160685379 | 2.05 |
ENST00000642502.1
|
ATP10B
|
ATPase phospholipid transporting 10B (putative) |
chr1_+_46798998 | 1.92 |
ENST00000640628.1
ENST00000271153.8 ENST00000371923.9 ENST00000371919.8 ENST00000614163.4 |
CYP4B1
|
cytochrome P450 family 4 subfamily B member 1 |
chr11_+_27040725 | 1.91 |
ENST00000529202.5
ENST00000263182.8 |
BBOX1
|
gamma-butyrobetaine hydroxylase 1 |
chr20_-_56525925 | 1.89 |
ENST00000243913.8
|
GCNT7
|
glucosaminyl (N-acetyl) transferase family member 7 |
chr6_-_134318097 | 1.75 |
ENST00000367858.10
ENST00000533224.1 |
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr1_-_205422050 | 1.74 |
ENST00000367153.9
|
LEMD1
|
LEM domain containing 1 |
chr6_+_26500296 | 1.72 |
ENST00000684113.1
|
BTN1A1
|
butyrophilin subfamily 1 member A1 |
chr7_+_80646436 | 1.70 |
ENST00000419819.2
|
CD36
|
CD36 molecule |
chr3_-_195811889 | 1.69 |
ENST00000475231.5
|
MUC4
|
mucin 4, cell surface associated |
chr17_+_62627628 | 1.51 |
ENST00000303375.10
|
MRC2
|
mannose receptor C type 2 |
chr7_+_80646305 | 1.48 |
ENST00000426978.5
ENST00000432207.5 |
CD36
|
CD36 molecule |
chr5_+_93583212 | 1.47 |
ENST00000327111.8
|
NR2F1
|
nuclear receptor subfamily 2 group F member 1 |
chr4_-_16898561 | 1.45 |
ENST00000515064.5
ENST00000441778.6 |
LDB2
|
LIM domain binding 2 |
chr9_-_110208156 | 1.40 |
ENST00000400613.5
|
C9orf152
|
chromosome 9 open reading frame 152 |
chr14_+_79279403 | 1.33 |
ENST00000281127.11
|
NRXN3
|
neurexin 3 |
chr8_-_7416863 | 1.32 |
ENST00000318157.3
|
DEFB4B
|
defensin beta 4B |
chr13_-_20230970 | 1.26 |
ENST00000644667.1
ENST00000646108.1 |
GJB6
|
gap junction protein beta 6 |
chr3_-_195811916 | 1.24 |
ENST00000463781.8
|
MUC4
|
mucin 4, cell surface associated |
chr15_-_89221558 | 1.23 |
ENST00000268125.10
|
RLBP1
|
retinaldehyde binding protein 1 |
chr5_-_35195236 | 1.21 |
ENST00000509839.5
|
PRLR
|
prolactin receptor |
chr7_-_41700583 | 1.19 |
ENST00000442711.1
|
INHBA
|
inhibin subunit beta A |
chr16_-_29899245 | 1.15 |
ENST00000537485.5
|
SEZ6L2
|
seizure related 6 homolog like 2 |
chr7_+_80638662 | 1.13 |
ENST00000394788.7
|
CD36
|
CD36 molecule |
chr19_-_51001591 | 1.12 |
ENST00000391806.6
|
KLK8
|
kallikrein related peptidase 8 |
chr3_-_195811857 | 1.08 |
ENST00000349607.8
ENST00000346145.8 |
MUC4
|
mucin 4, cell surface associated |
chr12_-_91111460 | 1.08 |
ENST00000266718.5
|
LUM
|
lumican |
chr12_-_91182652 | 1.07 |
ENST00000552145.5
ENST00000546745.5 |
DCN
|
decorin |
chr5_-_150289941 | 1.05 |
ENST00000682786.1
|
CAMK2A
|
calcium/calmodulin dependent protein kinase II alpha |
chr14_+_79279906 | 1.05 |
ENST00000428277.6
|
NRXN3
|
neurexin 3 |
chr5_-_150289764 | 1.04 |
ENST00000671881.1
ENST00000672752.1 ENST00000510347.2 ENST00000672829.1 ENST00000348628.11 |
CAMK2A
|
calcium/calmodulin dependent protein kinase II alpha |
chr7_+_80638633 | 1.03 |
ENST00000447544.7
ENST00000482059.6 |
CD36
|
CD36 molecule |
chr6_+_25279359 | 1.03 |
ENST00000329474.7
|
CARMIL1
|
capping protein regulator and myosin 1 linker 1 |
chr16_-_29899532 | 1.03 |
ENST00000308713.9
ENST00000617533.5 |
SEZ6L2
|
seizure related 6 homolog like 2 |
chr1_+_117001744 | 1.01 |
ENST00000256652.8
ENST00000682167.1 ENST00000369470.1 |
CD101
|
CD101 molecule |
chr8_+_40153475 | 1.00 |
ENST00000315792.5
|
TCIM
|
transcriptional and immune response regulator |
chr16_-_21278282 | 0.99 |
ENST00000572914.2
|
CRYM
|
crystallin mu |
chr14_+_22493910 | 0.99 |
ENST00000390492.1
|
TRAJ45
|
T cell receptor alpha joining 45 |
chr20_-_44187093 | 0.98 |
ENST00000342272.3
|
JPH2
|
junctophilin 2 |
chr11_+_27041313 | 0.95 |
ENST00000528583.5
|
BBOX1
|
gamma-butyrobetaine hydroxylase 1 |
chr6_+_19837362 | 0.94 |
ENST00000378700.8
|
ID4
|
inhibitor of DNA binding 4, HLH protein |
chr2_+_95297304 | 0.94 |
ENST00000295225.10
|
KCNIP3
|
potassium voltage-gated channel interacting protein 3 |
chr15_+_59611776 | 0.93 |
ENST00000396065.3
ENST00000560585.5 |
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr5_-_84384871 | 0.91 |
ENST00000296591.10
|
EDIL3
|
EGF like repeats and discoidin domains 3 |
chr1_-_205935822 | 0.91 |
ENST00000340781.8
|
SLC26A9
|
solute carrier family 26 member 9 |
chr11_+_64237420 | 0.90 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr19_-_48646155 | 0.89 |
ENST00000084798.9
|
CA11
|
carbonic anhydrase 11 |
chr22_+_22162155 | 0.86 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr3_-_132035004 | 0.86 |
ENST00000429747.6
|
CPNE4
|
copine 4 |
chr8_+_101492423 | 0.85 |
ENST00000521085.1
ENST00000646743.1 |
GRHL2
|
grainyhead like transcription factor 2 |
chr6_+_31946086 | 0.82 |
ENST00000425368.7
|
CFB
|
complement factor B |
chr12_-_91182784 | 0.82 |
ENST00000547568.6
ENST00000052754.10 ENST00000552962.5 |
DCN
|
decorin |
chr8_+_76683779 | 0.81 |
ENST00000523885.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr6_-_166862502 | 0.80 |
ENST00000510118.5
ENST00000503859.5 ENST00000506565.1 |
RPS6KA2
|
ribosomal protein S6 kinase A2 |
chr2_+_113437691 | 0.80 |
ENST00000259199.9
ENST00000416503.6 ENST00000433343.6 |
CBWD2
|
COBW domain containing 2 |
chr21_+_41322805 | 0.78 |
ENST00000398646.3
|
FAM3B
|
FAM3 metabolism regulating signaling molecule B |
chr7_-_101165558 | 0.76 |
ENST00000611537.1
ENST00000249330.3 |
VGF
|
VGF nerve growth factor inducible |
chr14_+_22112280 | 0.76 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr14_+_60509138 | 0.75 |
ENST00000327720.6
|
SIX6
|
SIX homeobox 6 |
chr4_-_76023489 | 0.74 |
ENST00000306602.3
|
CXCL10
|
C-X-C motif chemokine ligand 10 |
chr1_+_47023659 | 0.73 |
ENST00000371901.4
|
CYP4X1
|
cytochrome P450 family 4 subfamily X member 1 |
chr12_-_6374803 | 0.73 |
ENST00000396966.6
|
SCNN1A
|
sodium channel epithelial 1 subunit alpha |
chr4_+_155666827 | 0.73 |
ENST00000511507.5
ENST00000506455.6 |
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr12_-_6375209 | 0.72 |
ENST00000360168.7
|
SCNN1A
|
sodium channel epithelial 1 subunit alpha |
chr6_-_32178080 | 0.72 |
ENST00000336984.6
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 |
chr1_-_46132650 | 0.72 |
ENST00000372006.5
ENST00000425892.2 ENST00000420542.5 |
PIK3R3
|
phosphoinositide-3-kinase regulatory subunit 3 |
chr1_+_62597510 | 0.71 |
ENST00000371129.4
|
ANGPTL3
|
angiopoietin like 3 |
chr7_-_124765753 | 0.71 |
ENST00000303921.3
|
GPR37
|
G protein-coupled receptor 37 |
chr5_-_20575850 | 0.71 |
ENST00000507958.5
|
CDH18
|
cadherin 18 |
chr15_-_77696142 | 0.70 |
ENST00000561030.5
|
LINGO1
|
leucine rich repeat and Ig domain containing 1 |
chr1_+_161225939 | 0.70 |
ENST00000545897.5
|
TOMM40L
|
translocase of outer mitochondrial membrane 40 like |
chr1_+_161226045 | 0.70 |
ENST00000367988.8
|
TOMM40L
|
translocase of outer mitochondrial membrane 40 like |
chr5_-_150289625 | 0.69 |
ENST00000683332.1
ENST00000398376.8 ENST00000672785.1 ENST00000672396.1 |
CAMK2A
|
calcium/calmodulin dependent protein kinase II alpha |
chr5_-_160852200 | 0.69 |
ENST00000327245.10
|
ATP10B
|
ATPase phospholipid transporting 10B (putative) |
chr4_-_16898619 | 0.69 |
ENST00000502640.5
ENST00000304523.10 ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr19_-_49362376 | 0.68 |
ENST00000601519.5
ENST00000593945.6 ENST00000539846.5 ENST00000596757.1 ENST00000311227.6 |
TEAD2
|
TEA domain transcription factor 2 |
chrX_-_132489842 | 0.68 |
ENST00000436215.5
|
MBNL3
|
muscleblind like splicing regulator 3 |
chrX_-_132489954 | 0.68 |
ENST00000370844.5
|
MBNL3
|
muscleblind like splicing regulator 3 |
chr6_-_6006878 | 0.68 |
ENST00000244766.7
|
NRN1
|
neuritin 1 |
chr12_-_13095664 | 0.67 |
ENST00000337630.10
ENST00000545699.1 |
GSG1
|
germ cell associated 1 |
chr18_-_58629084 | 0.67 |
ENST00000361673.4
|
ALPK2
|
alpha kinase 2 |
chr15_-_74212219 | 0.67 |
ENST00000449139.6
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chr1_+_86424154 | 0.66 |
ENST00000370565.5
|
CLCA2
|
chloride channel accessory 2 |
chr11_+_130448633 | 0.66 |
ENST00000299164.4
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif 15 |
chr6_+_31927683 | 0.65 |
ENST00000456570.5
|
ENSG00000244255.5
|
novel complement component 2 (C2) and complement factor B (CFB) protein |
chr8_-_142769785 | 0.65 |
ENST00000521396.1
ENST00000317543.12 |
SLURP2
|
secreted LY6/PLAUR domain containing 2 |
chr1_-_177164673 | 0.65 |
ENST00000424564.2
ENST00000361833.7 |
ASTN1
|
astrotactin 1 |
chr19_+_40991274 | 0.65 |
ENST00000324071.10
|
CYP2B6
|
cytochrome P450 family 2 subfamily B member 6 |
chr6_+_36676455 | 0.65 |
ENST00000615513.4
|
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr3_-_132037800 | 0.64 |
ENST00000617767.4
|
CPNE4
|
copine 4 |
chr17_-_73092657 | 0.63 |
ENST00000580557.5
ENST00000579732.5 ENST00000578620.1 ENST00000542342.6 ENST00000255559.7 ENST00000579018.5 |
SLC39A11
|
solute carrier family 39 member 11 |
chr1_-_205449924 | 0.63 |
ENST00000367154.5
|
LEMD1
|
LEM domain containing 1 |
chr19_-_39934626 | 0.62 |
ENST00000616721.6
|
FCGBP
|
Fc fragment of IgG binding protein |
chr2_+_100820102 | 0.62 |
ENST00000335681.10
|
NPAS2
|
neuronal PAS domain protein 2 |
chr10_-_104085847 | 0.62 |
ENST00000648076.2
|
COL17A1
|
collagen type XVII alpha 1 chain |
chr4_+_73404255 | 0.62 |
ENST00000621628.4
ENST00000621085.4 ENST00000415165.6 ENST00000295897.9 ENST00000503124.5 ENST00000509063.5 ENST00000401494.7 |
ALB
|
albumin |
chr11_-_34511710 | 0.62 |
ENST00000620316.4
ENST00000312319.6 |
ELF5
|
E74 like ETS transcription factor 5 |
chr3_+_196744 | 0.62 |
ENST00000256509.7
ENST00000397491.6 |
CHL1
|
cell adhesion molecule L1 like |
chr13_-_67230313 | 0.62 |
ENST00000377865.7
|
PCDH9
|
protocadherin 9 |
chr2_-_213150236 | 0.61 |
ENST00000442445.1
ENST00000342002.6 |
IKZF2
|
IKAROS family zinc finger 2 |
chr12_-_121039204 | 0.61 |
ENST00000620239.5
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr12_-_121039236 | 0.61 |
ENST00000257570.9
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr19_+_49513353 | 0.61 |
ENST00000596975.5
|
FCGRT
|
Fc fragment of IgG receptor and transporter |
chr6_+_36676489 | 0.60 |
ENST00000448526.6
|
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr14_+_23376765 | 0.60 |
ENST00000649278.1
|
CMTM5
|
CKLF like MARVEL transmembrane domain containing 5 |
chr3_+_100609594 | 0.60 |
ENST00000273352.8
|
ADGRG7
|
adhesion G protein-coupled receptor G7 |
chr12_+_59664677 | 0.59 |
ENST00000548610.5
|
SLC16A7
|
solute carrier family 16 member 7 |
chr18_+_74499939 | 0.59 |
ENST00000584768.5
|
CNDP2
|
carnosine dipeptidase 2 |
chr6_+_146029059 | 0.58 |
ENST00000282753.6
|
GRM1
|
glutamate metabotropic receptor 1 |
chr1_+_206865620 | 0.58 |
ENST00000367098.6
|
IL20
|
interleukin 20 |
chr3_+_29281049 | 0.58 |
ENST00000383767.7
|
RBMS3
|
RNA binding motif single stranded interacting protein 3 |
chr12_-_121039156 | 0.58 |
ENST00000339275.10
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr12_+_101594849 | 0.58 |
ENST00000547405.5
ENST00000452455.6 ENST00000392934.7 ENST00000547509.5 ENST00000361685.6 ENST00000549145.5 ENST00000361466.7 ENST00000553190.5 ENST00000545503.6 ENST00000536007.5 ENST00000541119.5 ENST00000551300.5 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C1 |
chr11_-_44310126 | 0.56 |
ENST00000652299.1
|
ALX4
|
ALX homeobox 4 |
chr6_-_47042260 | 0.56 |
ENST00000371243.2
|
ADGRF1
|
adhesion G protein-coupled receptor F1 |
chrX_-_139642518 | 0.56 |
ENST00000370573.8
ENST00000338585.6 |
MCF2
|
MCF.2 cell line derived transforming sequence |
chr5_-_73448769 | 0.55 |
ENST00000615637.3
|
FOXD1
|
forkhead box D1 |
chr22_-_31292445 | 0.55 |
ENST00000402249.7
ENST00000215912.10 ENST00000443175.1 ENST00000441972.5 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr18_+_52340179 | 0.54 |
ENST00000442544.7
|
DCC
|
DCC netrin 1 receptor |
chr12_-_114406133 | 0.54 |
ENST00000405440.7
|
TBX5
|
T-box transcription factor 5 |
chr20_+_64164474 | 0.54 |
ENST00000622439.4
ENST00000536311.5 |
MYT1
|
myelin transcription factor 1 |
chr11_+_57338344 | 0.53 |
ENST00000263314.3
ENST00000616487.4 |
P2RX3
|
purinergic receptor P2X 3 |
chr20_-_675793 | 0.53 |
ENST00000488788.2
ENST00000246104.7 |
ENSG00000270299.1
SCRT2
|
novel protein scratch family transcriptional repressor 2 |
chr4_-_25863537 | 0.53 |
ENST00000502949.5
ENST00000264868.9 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
SEL1L family member 3 |
chr14_-_64942720 | 0.53 |
ENST00000557049.1
ENST00000389614.6 |
GPX2
|
glutathione peroxidase 2 |
chr3_-_125120813 | 0.53 |
ENST00000430155.6
|
SLC12A8
|
solute carrier family 12 member 8 |
chr20_+_64164566 | 0.53 |
ENST00000650655.1
|
MYT1
|
myelin transcription factor 1 |
chr6_+_32178389 | 0.52 |
ENST00000375094.4
|
RNF5
|
ring finger protein 5 |
chr2_+_233760265 | 0.52 |
ENST00000305208.10
ENST00000360418.4 |
UGT1A1
|
UDP glucuronosyltransferase family 1 member A1 |
chr13_-_51974775 | 0.52 |
ENST00000674147.1
|
ATP7B
|
ATPase copper transporting beta |
chr2_-_19358612 | 0.52 |
ENST00000272223.3
|
OSR1
|
odd-skipped related transcription factor 1 |
chr20_+_64164446 | 0.52 |
ENST00000328439.6
|
MYT1
|
myelin transcription factor 1 |
chr7_-_100177336 | 0.51 |
ENST00000292377.4
|
GPC2
|
glypican 2 |
chr19_-_55149193 | 0.51 |
ENST00000587758.5
ENST00000588981.6 ENST00000356783.9 ENST00000291901.12 ENST00000588426.5 ENST00000536926.5 ENST00000588147.5 |
TNNT1
|
troponin T1, slow skeletal type |
chrX_-_139642889 | 0.51 |
ENST00000370576.9
|
MCF2
|
MCF.2 cell line derived transforming sequence |
chr2_-_24085186 | 0.51 |
ENST00000335934.8
|
TP53I3
|
tumor protein p53 inducible protein 3 |
chrX_-_24647091 | 0.50 |
ENST00000356768.8
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr15_+_74812829 | 0.50 |
ENST00000309664.10
ENST00000379709.7 |
LMAN1L
|
lectin, mannose binding 1 like |
chr20_+_16748358 | 0.50 |
ENST00000246081.3
|
OTOR
|
otoraplin |
chr6_-_47042306 | 0.50 |
ENST00000371253.7
|
ADGRF1
|
adhesion G protein-coupled receptor F1 |
chr12_-_121038967 | 0.49 |
ENST00000680620.1
ENST00000679655.1 ENST00000543677.2 |
OASL
|
2'-5'-oligoadenylate synthetase like |
chr4_+_122826679 | 0.49 |
ENST00000264498.8
|
FGF2
|
fibroblast growth factor 2 |
chr16_-_29899043 | 0.49 |
ENST00000346932.9
ENST00000350527.7 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog like 2 |
chr2_-_215138603 | 0.49 |
ENST00000272895.12
|
ABCA12
|
ATP binding cassette subfamily A member 12 |
chr3_-_195583931 | 0.49 |
ENST00000343267.8
ENST00000421243.5 ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr10_-_99235846 | 0.48 |
ENST00000370552.8
ENST00000370549.5 ENST00000628193.2 |
HPSE2
|
heparanase 2 (inactive) |
chr4_-_47981535 | 0.48 |
ENST00000402813.9
|
CNGA1
|
cyclic nucleotide gated channel subunit alpha 1 |
chr19_+_49335396 | 0.48 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr1_+_160151597 | 0.48 |
ENST00000368081.9
|
ATP1A4
|
ATPase Na+/K+ transporting subunit alpha 4 |
chr9_-_35111423 | 0.47 |
ENST00000378557.1
|
FAM214B
|
family with sequence similarity 214 member B |
chr2_-_96740034 | 0.47 |
ENST00000264963.9
ENST00000377079.8 |
LMAN2L
|
lectin, mannose binding 2 like |
chr19_+_45001430 | 0.47 |
ENST00000625761.2
ENST00000505236.1 ENST00000221452.13 |
RELB
|
RELB proto-oncogene, NF-kB subunit |
chr2_+_90069662 | 0.47 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_-_29074515 | 0.47 |
ENST00000331664.6
|
PCARE
|
photoreceptor cilium actin regulator |
chr17_+_7484357 | 0.47 |
ENST00000674977.2
|
POLR2A
|
RNA polymerase II subunit A |
chr1_-_167090370 | 0.47 |
ENST00000367868.4
|
GPA33
|
glycoprotein A33 |
chr14_+_79280263 | 0.47 |
ENST00000555387.1
|
NRXN3
|
neurexin 3 |
chr2_+_104853259 | 0.47 |
ENST00000598623.1
ENST00000653688.1 ENST00000662784.1 ENST00000666977.1 ENST00000674056.1 |
ENSG00000269707.2
POU3F3
|
novel transcript, sense overlapping POU3F3 POU class 3 homeobox 3 |
chr16_+_30762289 | 0.46 |
ENST00000566811.5
ENST00000565995.5 ENST00000563683.5 ENST00000357890.9 ENST00000324685.11 ENST00000565931.1 |
RNF40
|
ring finger protein 40 |
chr4_-_25862979 | 0.46 |
ENST00000399878.8
|
SEL1L3
|
SEL1L family member 3 |
chr7_-_155812454 | 0.46 |
ENST00000297261.7
|
SHH
|
sonic hedgehog signaling molecule |
chr15_-_74212256 | 0.46 |
ENST00000416286.7
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chr11_+_111255982 | 0.46 |
ENST00000637637.1
|
C11orf53
|
chromosome 11 open reading frame 53 |
chr19_+_49688664 | 0.46 |
ENST00000420022.3
|
ADM5
|
adrenomedullin 5 (putative) |
chr3_-_147406520 | 0.46 |
ENST00000463250.1
ENST00000383075.8 |
ZIC4
|
Zic family member 4 |
chr17_-_7217206 | 0.46 |
ENST00000447163.6
ENST00000647975.1 |
DLG4
|
discs large MAGUK scaffold protein 4 |
chr1_-_13116854 | 0.45 |
ENST00000621994.3
|
HNRNPCL2
|
heterogeneous nuclear ribonucleoprotein C like 2 |
chr5_+_36608146 | 0.45 |
ENST00000381918.4
ENST00000513646.1 |
SLC1A3
|
solute carrier family 1 member 3 |
chr5_-_147782518 | 0.45 |
ENST00000507386.5
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr14_+_21868822 | 0.45 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr16_-_11273610 | 0.45 |
ENST00000327157.4
|
PRM3
|
protamine 3 |
chr11_+_55827219 | 0.45 |
ENST00000378397.1
|
OR5L2
|
olfactory receptor family 5 subfamily L member 2 |
chr11_-_102955705 | 0.45 |
ENST00000615555.4
ENST00000340273.4 ENST00000260302.8 |
MMP13
|
matrix metallopeptidase 13 |
chr3_+_47282930 | 0.45 |
ENST00000232766.6
ENST00000437353.5 |
KLHL18
|
kelch like family member 18 |
chr2_+_90021567 | 0.45 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr4_-_46993520 | 0.45 |
ENST00000264318.4
|
GABRA4
|
gamma-aminobutyric acid type A receptor subunit alpha4 |
chr4_+_155666963 | 0.44 |
ENST00000455639.6
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr14_+_103123452 | 0.44 |
ENST00000558056.1
ENST00000560869.6 |
TNFAIP2
|
TNF alpha induced protein 2 |
chr5_+_93584916 | 0.44 |
ENST00000647447.1
ENST00000615873.1 |
NR2F1
|
nuclear receptor subfamily 2 group F member 1 |
chr19_+_57128643 | 0.44 |
ENST00000598197.1
|
USP29
|
ubiquitin specific peptidase 29 |
chr15_+_90872862 | 0.44 |
ENST00000618099.4
|
FURIN
|
furin, paired basic amino acid cleaving enzyme |
chr11_-_111910888 | 0.44 |
ENST00000525823.1
ENST00000528961.6 |
CRYAB
|
crystallin alpha B |
chr14_-_75981986 | 0.43 |
ENST00000238682.8
|
TGFB3
|
transforming growth factor beta 3 |
chr1_+_50108856 | 0.43 |
ENST00000650764.1
ENST00000494555.2 ENST00000371824.7 ENST00000371823.8 ENST00000652693.1 |
ELAVL4
|
ELAV like RNA binding protein 4 |
chr6_-_166627244 | 0.43 |
ENST00000265678.9
|
RPS6KA2
|
ribosomal protein S6 kinase A2 |
chr8_+_84705920 | 0.43 |
ENST00000523850.5
ENST00000521376.1 |
RALYL
|
RALY RNA binding protein like |
chr12_+_106582996 | 0.43 |
ENST00000392842.6
|
RFX4
|
regulatory factor X4 |
chr11_-_124673708 | 0.43 |
ENST00000263593.8
|
SIAE
|
sialic acid acetylesterase |
chr1_+_156369202 | 0.43 |
ENST00000537040.6
|
RHBG
|
Rh family B glycoprotein |
chrX_+_73447042 | 0.42 |
ENST00000373514.3
|
CDX4
|
caudal type homeobox 4 |
chr10_-_52771700 | 0.42 |
ENST00000373968.3
|
MBL2
|
mannose binding lectin 2 |
chr1_-_27155118 | 0.42 |
ENST00000263980.8
|
SLC9A1
|
solute carrier family 9 member A1 |
chr4_+_155666718 | 0.42 |
ENST00000621234.4
ENST00000511108.5 |
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr15_-_43618240 | 0.42 |
ENST00000432436.1
|
STRC
|
stereocilin |
chr22_+_50545890 | 0.42 |
ENST00000648057.3
|
KLHDC7B
|
kelch domain containing 7B |
chr14_+_22271921 | 0.42 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
chr9_+_121299793 | 0.41 |
ENST00000373818.8
|
GSN
|
gelsolin |
chr9_+_68302867 | 0.41 |
ENST00000342833.4
|
FOXD4L3
|
forkhead box D4 like 3 |
chr3_+_115623502 | 0.41 |
ENST00000305124.11
ENST00000393780.3 |
GAP43
|
growth associated protein 43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.1 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.6 | 2.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.6 | 5.3 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.4 | 1.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.9 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.3 | 1.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 0.8 | GO:0051695 | actin filament uncapping(GO:0051695) |
0.3 | 2.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 0.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 1.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 1.2 | GO:0003166 | bundle of His development(GO:0003166) |
0.2 | 0.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.6 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 0.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 1.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.6 | GO:1903281 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.2 | 1.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.2 | 0.7 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
0.2 | 4.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
0.2 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.6 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.6 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 2.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.1 | 1.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.1 | 0.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.5 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) neuroblast differentiation(GO:0014016) |
0.1 | 0.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 4.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.3 | GO:2000697 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.1 | 0.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.3 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 0.3 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.3 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.1 | 0.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 1.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) B cell selection(GO:0002339) B cell cytokine production(GO:0002368) |
0.1 | 0.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 0.4 | GO:0038185 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 1.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.2 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.1 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.4 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 2.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.2 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.5 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.2 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.1 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.3 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.3 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 0.3 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.1 | 0.2 | GO:0038189 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) renal artery morphogenesis(GO:0061441) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.1 | 0.3 | GO:0048843 | positive regulation of axon extension involved in axon guidance(GO:0048842) negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.2 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.2 | GO:0031394 | maternal aggressive behavior(GO:0002125) positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.0 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 0.2 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.0 | 0.5 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.1 | GO:1904582 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.0 | 0.2 | GO:0035645 | posterior midgut development(GO:0007497) enteric smooth muscle cell differentiation(GO:0035645) |
0.0 | 0.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.1 | GO:0060873 | subpallium cell proliferation in forebrain(GO:0022012) lateral ganglionic eminence cell proliferation(GO:0022018) lambdoid suture morphogenesis(GO:0060366) sagittal suture morphogenesis(GO:0060367) anterior semicircular canal development(GO:0060873) lateral semicircular canal development(GO:0060875) |
0.0 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.3 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.0 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.1 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) |
0.0 | 0.3 | GO:2000620 | innate vocalization behavior(GO:0098582) positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.0 | 0.1 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.0 | 0.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.9 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
0.0 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 1.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.1 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.0 | 0.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.0 | 0.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 1.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.2 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 1.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.1 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.4 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:1990451 | cellular stress response to acidic pH(GO:1990451) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.2 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.1 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 2.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.6 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.0 | 2.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.0 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.0 | 0.0 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0044334 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.0 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.2 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.0 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 2.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.0 | 0.6 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.0 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.2 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0048691 | modulation by virus of host transcription(GO:0019056) axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.0 | 0.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.0 | 0.3 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 1.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.2 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.2 | 0.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.2 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 1.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 5.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0060987 | lipid tube(GO:0060987) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 1.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) periciliary membrane compartment(GO:1990075) |
0.1 | 0.2 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 3.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 1.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.7 | 5.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.6 | 3.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 0.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.2 | 1.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 1.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.2 | 1.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.7 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 5.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 0.5 | GO:0030305 | heparanase activity(GO:0030305) |
0.2 | 0.5 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.2 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 3.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.4 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
0.1 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 1.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 2.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 1.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.2 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0043273 | CTPase activity(GO:0043273) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.7 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.3 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.0 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 3.8 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 3.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.0 | 0.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.0 | 0.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 4.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 4.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 6.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 2.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |